Vis enkel innførsel

dc.contributor.authorDankel, Simon Nitter
dc.contributor.authorKalleklev, Tine-Lise
dc.contributor.authorTungland, siri Lunde
dc.contributor.authorStafsnes, Marit Hallvardsdotter
dc.contributor.authorBruheim, Per
dc.contributor.authorAloysius, Thomas Aquinas
dc.contributor.authorLindquist, Carine
dc.contributor.authorSKORVE, JON
dc.contributor.authorNygård, Ottar Kjell
dc.contributor.authorMadsen, Lise
dc.contributor.authorBjørndal, Bodil
dc.contributor.authorSydnes, Magne Olav
dc.contributor.authorBerge, Rolf Kristian
dc.date.accessioned2023-11-10T09:52:33Z
dc.date.available2023-11-10T09:52:33Z
dc.date.created2023-11-07T19:42:46Z
dc.date.issued2023
dc.identifier.issn1661-6596
dc.identifier.urihttps://hdl.handle.net/11250/3101818
dc.description.abstractAltered hepatic mitochondrial fatty acid β-oxidation and associated tricarboxylic acid (TCA) cycle activity contributes to lifestyle-related diseases, and circulating biomarkers reflecting these changes could have disease prognostic value. This study aimed to determine hepatic and systemic changes in TCA-cycle-related metabolites upon the selective pharmacologic enhancement of mitochondrial fatty acid β-oxidation in the liver, and to elucidate the mechanisms and potential markers of hepatic mitochondrial activity. Male Wistar rats were treated with 3-thia fatty acids (e.g., tetradecylthioacetic acid (TTA)), which target mitochondrial biogenesis, mitochondrial fatty acid β-oxidation, and ketogenesis predominantly in the liver. Hepatic and plasma concentrations of TCA cycle intermediates and anaplerotic substrates (LC-MS/MS), plasma ketones (colorimetric assay), and acylcarnitines (HPLC-MS/MS), along with associated TCA-cycle-related gene expression (qPCR) and enzyme activities, were determined. TTA-induced hepatic fatty acid β-oxidation resulted in an increased ratio of plasma ketone bodies/nonesterified fatty acid (NEFA), lower plasma malonyl-CoA levels, and a higher ratio of plasma acetylcarnitine/palmitoylcarnitine (C2/C16). These changes were associated with decreased hepatic and increased plasma pyruvate concentrations, and increased plasma concentrations of succinate, malate, and 2-hydroxyglutarate. Expression of several genes encoding TCA cycle enzymes and the malate–oxoglutarate carrier (Slc25a11), glutamate dehydrogenase (Gdh), and malic enzyme (Mdh1 and Mdh2) were significantly increased. In conclusion, the induction of hepatic mitochondrial fatty acid β-oxidation by 3-thia fatty acids lowered hepatic pyruvate while increasing plasma pyruvate, as well as succinate, malate, and 2-hydroxyglutarate. Keywords: mitochondria; liver; fatty acid oxidation; ketogenesis; biomarkersen_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleChanges in Plasma Pyruvate and TCA Cycle Metabolites upon Increased Hepatic Fatty Acid Oxidation and Ketogenesis in Male Wistar Ratsen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2023 by the authorsen_US
dc.source.volume24en_US
dc.source.journalInternational Journal of Molecular Sciencesen_US
dc.source.issue15536en_US
dc.identifier.doi10.3390/ijms242115536
dc.identifier.cristin2193546
dc.source.articlenumber15536en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal